NAD+ injection cost: what do online plans charge?

Among the injection offers in this comparison with a clear payment schedule, Embody publishes the lowest initial plan payment: $49.00 for the first month, followed by $99.00 per month. The first-month price is a limited promotion, so confirm it is available for your order. Luvo lists $99.50 for the first four weeks, then $199.00 every four weeks. AgelessRx's $79.00 first-month offer requires a three-month plan billed in full; the complete initial bill is not clearly published. System Labs' $89 headline does not clearly resolve the injection selection or later charge. These are published plan amounts, not verified checkout totals or equivalent supplies. Unknown quantities and additional costs prevent a cheapest complete-treatment claim.

Source records: September 15, 2026; September 26, 2026; October 13, 2026; October 27, 2026: nad.joinem.co · luvohealth.com · agelessrx.com · systemlabs.com. This is a comparison of the listed offers, not an exhaustive market search or a clinical ranking.

Read the Embody review for the product and contract limits. RNK also advertises a $99 monthly headline, but its complete first bill and subsequent charge remain unverified. Check the RNK pricing questions.

Sprout's selected landing publishes the later four-week bill; System Labs' NAD+ page does not expressly state its renewal or conclusively tie the $76 headline to injection rather than nasal use. The selected checkout controls both offers. Read the side-by-side NAD+ comparison.

Sprout Health’s NAD+ injection referral offer excludes California.

RNK's selected NAD+ injection landing advertises a $99 monthly promotional rate, while its general homepage shows a different from-$129 headline. The public selected page does not establish the exact next bill, and RNK's product-page guarantee sits uneasily beside its refund policy. The RNK Health review compares those sources and lists the checkout questions for this exact injection. Read RNK's selected NAD+ product source.

No. SHED's product cards separate the $144.00 nasal starting rate from injections starting at $169.00 per advertised month. Neither headline establishes your first bill or complete treatment cost. SHED NAD product cards, checked September 19, 2026.

The minimum commitment also needs clarification: its general terms and cancellation help do not agree. We have not multiplied the starting rate into a supposed minimum bill. Read the SHED NAD review and the two policy sources before relying on a one-month or cancel-anytime assumption.

No. This page compares at-home injection plans, including TMates' subcutaneous product. An IV infusion is a different route and service; these plan prices are not quotes for clinic IV treatment. The small NAD+ human study cited in our evidence guide used an IV infusion, so its findings cannot be treated as results for the injection subscriptions priced here. Grant et al.: human NAD+ IV pilot (2019)

Embody's published schedule implies an initial $49.00 payment followed by two $99.00 renewals, or $247.00, across three monthly billing events. Pallas lists a $139 first month and $179 every four weeks afterward, but the first renewal date is not explicit enough to calculate its first 90-day total. These are plan-payment calculations, not claims that the quantities match. A complete comparison still cannot be calculated for every offer because Luvo's exact renewal processing date and AgelessRx's first prepaid total need confirmation. Embody product pricing; Pallas product pricing; Luvo product pricing; AgelessRx offer.

Open the payment explorer to inspect known charges and unresolved inputs. Ask the provider for a written first bill, next processing date and renewal amount before using any schedule as a budget.

Wellorithm advertises $150 for the first month and $200 per month afterward. Its NAD+ footnote ties that rate to a three-month plan paid upfront or through financing. The complete first bill and later payment schedule remain unverified. An advertised rate alone cannot establish the cheapest payment or a comparable supply. Wellorithm NAD+ product source.

Read the Wellorithm NAD+ offer and payment questions before comparing its headline with a verified first charge.

No. Four weeks is 28 days, so thirteen four-week periods cover 364 days. Twelve calendar-month periods cover a year. Luvo's published $199.00 four-week renewal and Embody's $99.00 monthly renewal therefore use different billing schedules. Do not compare their advertised rates as though both were monthly. The actual first renewal date, early processing and any introductory offer can also change which charges fall inside your budget window.

Luvo published billing interval; Embody monthly plan.

Ask for a written quote covering the assessment, medication quantity, supplies, shipping, required laboratory tests, follow-up and any membership charge. Embody advertises evaluation, prescription if approved and shipping in its offer of $49.00 for the first month and $99.00 per month afterward. The exact supplied quantity and any additional costs for your selected order still need confirmation. An inclusion on a general platform page may not apply to every product. A cost marked "not verified" in this comparison is unknown, not free.

Embody product inclusions. The records also distinguish when the initial charge occurs. Pallas's terms say new purchases are charged only after a prescription, while Luvo's product and refund pages give different signals about charging at intake. See the Pallas review and Luvo review for the source details.

Use this request to get a written quote for the exact plan offered to you. It does not require you to share medical details with this site. Send it through the provider's own support channel, and leave unanswered amounts marked unknown rather than treating them as zero.

Please confirm the total collected today, whether it is charged before clinical approval, and what is refundable if no prescription is issued. What medication quantity, supplies, shipping, assessment and required labs does that payment include? What amount will be charged next, on which processing date, and for what quantity? Is there a minimum paid term or promotional-price expiry? What is the last date to cancel before that charge, and which payments are nonrefundable?

Save the dated reply and the terms attached to your order. Compare the initial bill, the next bill and what each includes as separate fields. A provider's reply may resolve one of the gaps in our dated source records; it does not establish that another provider supplies an equivalent treatment.

If a required amount or billing condition remains unclear, the payment explorer cannot turn it into a reliable all-in total. Resolve that uncertainty before authorizing payment; a lower advertised number alone is not enough to identify the better-value plan.

The evidence does not support turning price into an effectiveness score. The NAD+ human pilot examined a short IV infusion and metabolite changes, not whether an at-home subscription improves long-term health. Grant et al.: human NAD+ IV pilot (2019)

Decide with a clinician what outcome would justify treatment and how it would be assessed. The site can make the financial terms clearer, but cannot decide that the benefit is worth the cost for you.

TMates lists $149 for one month, $400 for three, $650 for six and $1,050 for twelve months. Those are published term totals; the checkout schedule and amount supplied for every term still need confirmation. Our TMates NAD+ review shows the arithmetic and the policy questions without adding an unverified row to this price table. TMates product source.

HealthRX lists NAD+ injections and sermorelin in its longevity catalog. Our source-based review compares its selected monthly prices, post-purchase clinical intake, subscription and refund policies. These buttons preserve the approved NAD+ product, sermorelin information and catalog destinations.

Partner links: HealthRX has approved Longevity Ranked through Katalys. These links track referrals. Current terms exclude NAD+ and sermorelin purchases from commission; other qualifying purchases may earn us a commission. Relationship disclosure.

Review sources checked September 29, 2026. Confirm the final price, renewal, dispensing pharmacy and eligibility with HealthRX. Listing a provider is not a clinical endorsement. Official catalog source.